1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
(
- Contribution to journal › Article
- 2002
-
Mark
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors
(
- Contribution to journal › Article
- 2001
-
Mark
New separation tools for comprehensive studies of protein expression by mass spectrometry
(
- Contribution to journal › Article
-
Mark
Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry
(
- Contribution to journal › Article
-
Mark
Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Identification of proteins from Escherichia coli using two-dimensional semi-preparative electrophoresis and mass spectrometry
(
- Contribution to journal › Article
-
Mark
Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders
(
- Contribution to journal › Article
-
Mark
The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids
(
- Contribution to journal › Article
-
Mark
Both total and phosphorylated tau are increased in Alzheimer's disease
(
- Contribution to journal › Article